Experience

• 

  State research institute of eye disease of russian academy of medical sciences

  Jan 2003 - May 2012

  Scientific employee

  Diagnostics of eye diseases, ultrasound diagnostics in ophthalmology, preclinical and clinical study in ophthalmologyGrant Rottapharm Madaus (Hepatic injury in drug therapy, 2010)Grant of the President of the Russian Federation (The effectiveness of antioxidant drugs in the treatment of retinal and vitreous pathology, 2006)

• 

  Jsc pharmstandart

  May 2012 - Jan 2015

  Medical adviser

  OTC products Russia (gastroenterology - Acipol, Neosmectin, dermatology - Cinocap, baby food - Lactazar) & Rx (vaccines) products

• 

  Bayer healthcare

  Jan 2015 - Jan 2020

  Medical adviser

  Medical support for OTC market (gastroenterology - Iberogast, Relief, Rennie; dermatology / cosmetics - Advantan, Bepanthen, Skinoren, joint diseases - NSAIDs - Aleve, etc.); digital HCP and DTC promotion; education activities for FF; strategic contacts with TAEs; medical information and PV-monitoring.

• 

  Roche

  Jan 2020 - now

  Medical lead

  Medical strategy for infectious diseases Rx (Xofluza in influenza, Actemra and Ronapreve in COVID-19) and Pipeline portfolio (neuroscience, rheumatology, orphan diseases etc); pre-launch activity, portfolio development; strategic partnership with TAEs; digital solutions for HCPs and patient eco-system; strategic planning of studies phase 3-4, RWD; publication policy; medical information solutions; education for external and internal stakeholders; strategic partnership with the diagnostic department. Daha az göster